Hermanus Bernardus Johannes Karperien

Chapter 1 – Stem cells

Publisher Summary This chapter defines stem cells and their properties. It identifies the major differences between embryonic and adult stem cells. Stem cells can be defined by two properties: the ability to make identical copies of themselves and the ability to form other cell types of the body. These properties are also referred to as “stemness.” Stem cells may potentially provide an unlimited supply of cells that can form any of the hundreds of specialized cells in the body. It is because of these properties that stem cells are an interesting cell source for tissue engineers. Stem cells can be divided into two main groups: embryonic and adult or somatic stem cells. Embryonic stem cells are responsible for embryonic and fetal development and growth. In the human body, adult stem cells are responsible for growth, tissue maintenance and regeneration and repair of diseased or damaged tissue. Embryonic stem cells do not exist in the body. When cells are isolated from the inner cell mass of the blastocyst, they can be massively expanded in the laboratory, while maintaining their pluripotency. Adult stem cells are undifferentiated cells, which reside in differentiated tissues.

Microwell scaffolds for extrahepatic islet of Langerhans transplantation in type 1 diabetes

Evaluation of air contamination incidences and in vitro settings and experiences of micro bubblesThe use of citrate-containing dialysate for anticoagulation in hemodialysis (hd). report of clinical experienceK1 (EI0154) AGES IN HEMODIALYSIS: TISSUEAND PLASMAAUTOFLUORESCENCE R. Graaff1, S. Arsov1, L. Trajceska4, P. Dzekova4, G.E. Engels1, M. Koetsier1, W. van Oeveren1, L Lundberg5, S. Assa2, C.F.M. Franssen2, A.J. Smit3, G. Rakhorst1, A. Sikole2, B. Stegmayr5 1Dept. of Biomedical Engineering, 2Internal Medicine, Div. Nephrology and 3Div. Vascular Medicine, University Medical Center Groningen, Groningen, The Netherlands; 4Department of Nephrology, University Clinic of Nephrology, Skopje, R. Macedonia; 5Department of Internal Medicine, University Hospital, Umea, SwedenObjectives: During HD previous studies have shown that especially micro bubbles of air may pass the air detector. These studies focused to analyse in vitro if the air trap of various producers may ...Artificial Kidney – Uremic Toxins – SYMPOSIUM, 606 Smart and Responsive Biomaterials – SYMPOSIUM, 607 Cardiovascular General 1: Devices – GENERAL SESSION, 608 Ambulatory Blood Processing – SYMPOSIUM, 610 Animal Models for Tissue Engineering – SYMPOSIUM, 610 Cardiovascular General 2: Devices Interaction – GENERAL SESSION, 612 Artificial Muscle for Internal Organ – SYMPOSIUM, 613 Functionalized Biomaterials – SYMPOSIUM, 614 Cardiovascular General 3: Physiology and Pump Control – GENERAL SESSION, 615 Vascular Access in Hemodialysis – SYMPOSIUM, 617 Polymeric Membranes/Blood Interfaces – SYMPOSIUM, 618 Nano and Micro Technology: Driving the Future of Organ Recovery & Development – SYMPOSIUM, 619 Roadbumps for Tissue-Engineering Artificial Organs – SYMPOSIUM, 621 Artificial Liver GENERAL SESSION, 621 Tissue Engineering Approaches – SYMPOSIUM, 622 Cardiovascular General 4: Cardiopulmonary – GENERAL SESSION, 624 Artificial Kidney Dialysis – SYMPOSIUM, 625 Tissue Engineering of Skin: Creating a New Bio-Artificial Organ for Clinical Application – SYMPOSIUM, 627 Cardiovascular General 5: Device & Biology – GENERAL SESSION, 628 Citrate Anticoagulation A Future Option for Extracorporeal Blood Purification – SYMPOSIUM, 629 Latest Advances in Preventive and Regenerative Medicine Technologies – SYMPOSIUM, 630 Intra-Aortic Balloon Pump as a Cardiac Assist Device – SYMPOSIUM, 631 Artificial Organ Transplantation – SYMPOSIUM, 632 New Biomaterials and Scaffolds – SYMPOSIUM, 633 Modelling of Cardiovascular and Pulmonary Function in Regard to Clinical Applications – SYMPOSIUM, 634 Artificial Kidney Dialysis Techniques – SYMPOSIUM, 635 Natural Based Polymeric Biomaterials and Composites for Regenerative Medicine – SYMPOSIUM, 637 Partial Cardiac Support in Shortand Long-Term Application – SYMPOSIUM, 638 Artificial Organs – Practical Applications – GENERAL SESSION, 639 Non-Destructive Techniques to Monitor 3D In Vitro Tissue Engineering Constructs – SYMPOSIUM, 640 Stent and Vascular Prosthesis – GENERAL SESSION, 641 Dialysis Techniques Access – GENERAL SESSION, 643 Scaffolds for TE Via Electrospinning-Structures and Biomaterials – SYMPOSIUM, 644 Drug Delivery Systems – GENERAL SESSION, 646 “Approval Procedures for Medical Devices: Facts, Figures and Basic Rules Seen from Different Continental Perspectives – Artificial Organs and Society: Recent Trends in Japan”, 647K1 (EI0154) AGES IN HEMODIALYSIS: TISSUEAND PLASMAAUTOFLUORESCENCE R. Graaff1, S. Arsov1, L. Trajceska4, P. Dzekova4, G.E. Engels1, M. Koetsier1, W. van Oeveren1, L Lundberg5, S. Assa2, C.F.M. Franssen2, A.J. Smit3, G. Rakhorst1, A. Sikole2, B. Stegmayr5 1Dept. of Biomedical Engineering, 2Internal Medicine, Div. Nephrology and 3Div. Vascular Medicine, University Medical Center Groningen, Groningen, The Netherlands; 4Department of Nephrology, University Clinic of Nephrology, Skopje, R. Macedonia; 5Department of Internal Medicine, University Hospital, Umeå, SwedenDoes the advanced glycation end-products (ages) food intake influence mortality in dialysis patients?